ViraTherapeutics GmbH:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:ViraTherapeutics GmbH - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C11318
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:18
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:オーストリア
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
ViraTherapeutics GmbH (ViraTherapeutics) is a biotechnology company that develops high potential anti-cancer therapeutics based on cancer-destroying oncolytic viruses. The company provides VSV-GP which is a proprietary oncolytic virus platform, which helps in destroying cancer cells and is used in treating a wide range of cancers. It performs preclinical safety and efficacy studies for VSV-GP and conducts first clinical trials in cancer patients. ViraTherapeutics VSV-GP contains glycoprotein of the vesicular stomatitis virus which has been replaced by the glycoprotein of the lymphocytic choriomeningitis virus to prevent the virus from the immune system. The company operates in Austria. ViraTherapeutics is headquartered in Innsbruck, Austria.

ViraTherapeutics GmbH – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
ViraTherapeutics GmbH, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
ViraTherapeutics GmbH, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
ViraTherapeutics GmbH, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
ViraTherapeutics GmbH, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
ViraTherapeutics GmbH, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
ViraTherapeutics GmbH, Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
ViraTherapeutics Raises USD4 Million in Series A Venture Financing 10
Partnerships 11
Boehringer Ingelheim Enters into Agreement with ViraTherapeutics 11
Equity Offering 12
ViraTherapeutics Spin Out from Innsbruck Medical University 12
Acquisition 13
Boehringer Ingelheim Acquires ViraTherapeutics for USD210 Million 13
ViraTherapeutics GmbH – Key Competitors 14
ViraTherapeutics GmbH – Key Employees 15
ViraTherapeutics GmbH – Locations And Subsidiaries 16
Head Office 16
Recent Developments 17
Corporate Communications 17
May 30, 2017: ViraTherapeutics appoints Heinz Schwer as CEO 17
Appendix 18
Methodology 18
About GlobalData 18
Contact Us 18
Disclaimer 18

List of Tables
ViraTherapeutics GmbH, Pharmaceuticals & Healthcare, Key Facts 2
ViraTherapeutics GmbH, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
ViraTherapeutics GmbH, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
ViraTherapeutics GmbH, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
ViraTherapeutics GmbH, Deals By Therapy Area, 2012 to YTD 2018 8
ViraTherapeutics GmbH, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
ViraTherapeutics Raises USD4 Million in Series A Venture Financing 10
Boehringer Ingelheim Enters into Agreement with ViraTherapeutics 11
ViraTherapeutics Spin Out from Innsbruck Medical University 12
Boehringer Ingelheim Acquires ViraTherapeutics for USD210 Million 13
ViraTherapeutics GmbH, Key Competitors 14
ViraTherapeutics GmbH, Key Employees 15

List of Figures
ViraTherapeutics GmbH, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
ViraTherapeutics GmbH, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
ViraTherapeutics GmbH, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
ViraTherapeutics GmbH, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
ViraTherapeutics GmbH, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
ViraTherapeutics GmbH, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
ViraTherapeutics GmbH, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
ViraTherapeutics GmbH, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[ViraTherapeutics GmbH:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Amicus Therapeutics Inc (FOLD):製薬・医療:M&Aディール及び事業提携情報
    Summary Amicus Therapeutics Inc (Amicus Therapeutics) is a biotechnology company that focuses on the research, development and commercialization of small molecules drugs and orally administered drugs known as pharmacological chaperones for the treatment of rare and orphan diseases. The company's lea …
  • Sun Pharma Advanced Research Company Ltd (SPARC)-製薬・医療分野:企業M&A・提携分析
    Summary Sun Pharma Advanced Research Company Ltd (SPARC), a subsidiary of Sun Pharmaceutical Industries Ltd is a pharma research and drug discovery company that conducts research and and produces drugs. The company develops active pharmaceutical ingredients, formulations and drug delivery technologi …
  • Dorel Industries Inc.:企業の戦略・SWOT・財務情報
    Dorel Industries Inc. - Strategy, SWOT and Corporate Finance Report Summary Dorel Industries Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Eydo Pharma SAS:製薬・医療:M&Aディール及び事業提携情報
    Summary Eydo Pharma SAS (Eydo Pharma) develops anti-bacterial medicines from essential oils and natural plant molecules for the treatment of infections caused by resistant bacteria. The company developed a pipeline of compounds and formulations such as EP1012, EP1010, EP1011, EP1014, EP1015, EP1020 …
  • STR Holdings Inc:企業の戦略的SWOT分析
    STR Holdings Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servi …
  • Luye Pharma Group Co Ltd (2186):製薬・医療:M&Aディール及び事業提携情報
    Summary Luye Pharma Group Co Ltd (Luye Pharma) is a pharmaceutical company that develops, produces and markets pharmaceutical products in the therapeutic areas of oncology, cardiovascular, metabolism and central nervous system. The company’s products include sodium aescinate for injection, xuezhikan …
  • Denbury Resources Inc.:企業の戦略・SWOT・財務分析
    Denbury Resources Inc. - Strategy, SWOT and Corporate Finance Report Summary Denbury Resources Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • A. O. Smith Corporation (AOS):企業の財務・戦略的SWOT分析
    A. O. Smith Corporation (AOS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Drummond Company Inc:企業の戦略・SWOT・財務情報
    Drummond Company Inc - Strategy, SWOT and Corporate Finance Report Summary Drummond Company Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Infineum International Ltd:企業の戦略的SWOT分析
    Infineum International Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • China Mobile Limited:戦略・SWOT・企業財務分析
    China Mobile Limited - Strategy, SWOT and Corporate Finance Report Summary China Mobile Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • CMA CGM SA:企業の戦略・SWOT・財務情報
    CMA CGM SA - Strategy, SWOT and Corporate Finance Report Summary CMA CGM SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • Lotte Chemical Corp (011170):企業の財務・戦略的SWOT分析
    Lotte Chemical Corp (011170) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • First Light Biosciences Inc:製品パイプライン分析
    Summary First Light Biosciences Inc (FLB) is a medical device company that develops and manufactures automated medical diagnostic products for detection of healthcare associated infections. The company’s product include multipath analyzer. Its multipath analyzer detects resistant and sensitive staph …
  • Otsuka Corp (4768):企業の財務・戦略的SWOT分析
    Otsuka Corp (4768) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Stemline Therapeutics Inc (STML):製薬・医療:M&Aディール及び事業提携情報
    Summary Stemline Therapeutics Inc (Stemline) is a clinical stage biopharmaceutical company that develops therapeutics to treat cancer stem cells and tumor bulk. The company has developed discovery platform StemScreen to identify novel compounds that target and kill cancer stem cells. Its products pi …
  • The Saudi Arabian Monetary Agency:企業の戦略的SWOT分析
    The Saudi Arabian Monetary Agency - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major p …
  • GNC Holdings, Inc.:企業の戦略・SWOT・財務情報
    GNC Holdings, Inc. - Strategy, SWOT and Corporate Finance Report Summary GNC Holdings, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • JSFC Sistema (AFKS):企業の財務・戦略的SWOT分析
    JSFC Sistema (AFKS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • Claris Lifesciences Ltd (533288)-製薬・医療分野:企業M&A・提携分析
    Summary Claris Lifesciences Ltd (Claris) is a manufacturer of generic drugs and pharmaceutical products. The company offers generic drugs that are directly injected into the human body, which is mainly used in the treatment of critical illnesses. Its products are offered through various delivery sys …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆